- Research works
- 4 fractional, all time
- Citations
- 9 2.1 per fractional work
- Top-10% rate
- 5.8% record average 16.5%
- Open access
- 68% world 28%
Not ranked overall: Implantica (Switzerland) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Which research topics does Implantica (Switzerland) publish most on?
By volume in 2022–2025: Gastroesophageal reflux and treatments, Eosinophilic Esophagitis, Esophageal Cancer Research and Treatment and Vascular anomalies and interventions.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Gastroesophageal reflux and treatments Gastroenterology 2 works
- 2 Eosinophilic Esophagitis Surgery 1 works
- 3 Esophageal Cancer Research and Treatment Surgery 0 works
- 4 Vascular anomalies and interventions Surgery 0 works
- 5 Esophageal and GI Pathology Surgery 0 works
- 6 Bariatric Surgery and Outcomes Surgery 0 works
- 7 Cardiac pacing and defibrillation studies Cardiology and Cardiovascular Medicine 0 works
- 8 Gastrointestinal motility and disorders Gastroenterology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
Other research institutions in Zug
- Varian Medical Systems (Switzerland)
- Biogen (Switzerland)
- University of Teacher Education Zug
- Amgen (Switzerland)
- AstraZeneca (Switzerland)
- RHI Magnesita (Switzerland)
- Johnson & Johnson (Switzerland)
- SHL Medical (Switzerland)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.